VNUS Medical Technologies (VNUS) soared to a new high on Friday on a deal to be acquired by Covidien for $440 million. Shares soared to $28.76, up $7.44 for the session. The rally took the stock above a support level that had lasted several months.
The company also reported first quarter net income of $1.86 million or $0.11 per share, compared to a net loss of $420 thousand or $0.03 per share last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.